Rena Morita
- Oncology top 5%
- Cancer Cells and Metastasis 10
- Cancer Immunotherapy and Biomarkers 9
- Immunology top 10%
- Immunotherapy and Immune Responses 8
- Cancer Research top 10%
- Biotechnology top 10%
- Cancer Research and Treatments 3
-
- Epigenetics and DNA Methylation 3
- RNA Interference and Gene Delivery 2
- vaccines and immunoinformatics approaches 2
-
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Toshihiko TorigoeYoshihiko HirohashiNoriyuki SatoAkari TakahashiYasuaki TamuraHiroko AsanumaTôru KondoTadashi Hasegawa
- Cited by
- OncologyImmunologyCancer Research
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (3 papers)Cancer Research (1 paper)
- Partner nations
- JapanUnited StatesNetherlands
In The Last Decade
Rena Morita
35 papers receiving 934 citations
Peers
Comparison fields: 5 of 77
- Oncology 577
- Immunology 303
- Cancer Research 178
- Biotechnology 77
- Molecular Biology 429
Countries citing papers authored by Rena Morita
This map shows the geographic impact of Rena Morita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rena Morita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rena Morita more than expected).
Fields of papers citing papers by Rena Morita
This network shows the impact of papers produced by Rena Morita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rena Morita. The network helps show where Rena Morita may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rena Morita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 14 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 3 | |
| 8 | 2016 | 9 | |
| 9 | 2014 | 8 | |
| 10 | 2013 | 10 | |
| 11 | 2013 | 89 | |
| 12 | 2013 | 59 | |
| 13 | 2012 | 101 | |
| 14 | 2012 | 27 | |
| 15 | 2011 | 109 | |
| 16 | 2011 | 97 | |
| 17 | 2010 | 39 | |
| 18 | [Hypogammaglobulinemia with a clinical course similar to that of drug-induced hypersensitivity syndrome]. | 2009 | 1 |
| 19 | 2008 | 35 | |
| 20 | 2008 | 38 |
About Rena Morita
Rena Morita is a scholar working on Oncology, Immunology and Genetics, having authored 36 papers that have together received 943 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (8 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Research and Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), RNA Interference and Gene Delivery (2 papers) and vaccines and immunoinformatics approaches (2 papers). The work is most often cited by research in Oncology (577 citations), Immunology (303 citations) and Cancer Research (178 citations). Rena Morita has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Toshihiko Torigoe, Yoshihiko Hirohashi, Noriyuki Sato, Akari Takahashi, Yasuaki Tamura, Hiroko Asanuma, Tôru Kondo, Tadashi Hasegawa, Satoko Inoda and Takayuki Kanaseki. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.